A new personalized blood test can detect recurrence of cancer. This new technique called personalized analysis of rearranged ends (Pare), was developed with blood from 6 sets of cancerous and normal tissue taken from four patients with colorectal cancer and two patients with breast cancer. They found that generally, the tumor markers fell after removal of the main tumor, but rose up again after some time suggesting that some cancer cells were left. However, with chemotherapy, the tumor markers again fell. Further research needs to be done to polish this technique. Dr. Luis Diaz, co-author of the study believes that this method could eventually detect recurrent cancers even before they can be detected in conventional diagnostic tools such as CT Scans.
This post is tagged aspirin, breast cancer, cancer, ibuprofen, Pare, Parkinson's Disease, Parkinsonism, tumor recurrence